Tirzepatide emerges a groundbreaking therapeutic agent for individuals facing type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://louisetapt227233.ivasdesign.com/61705727/tirzepatide-a-new-frontier-in-diabetes-treatment